All Stories

  1. Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients
  2. =====
  3. Immune Defence: Role of Reactive Nitrogen Intermediates
  4. Locally advanced paranasal sinus carcinoma: A study of 30�patients
  5. Risk stratification in prostate cancer treated with radiation therapy: a window of opportunity for new clinical trials
  6. A Voxel-Based Approach to Explore Local Dose Differences Associated With Radiation-Induced Lung Damage
  7. Dose-surface analysis for prediction of severe acute radio-induced skin toxicity in breast cancer patients
  8. Bluetooth devices for the optimization ofpatients' workflow in a radiation oncology department
  9. Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
  10. Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer
  11. Predicting radiation-induced valvular heart damage
  12. Ionizing Radiation Detectors Based on Ge-Doped Optical Fibers Inserted in Resonant Cavities
  13. Radioresistance in head and neck squamous cell carcinoma: Biological bases and therapeutic implications
  14. Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
  15. Complication Probability Models for Radiation-Induced Heart Valvular Dysfunction: Do Heart-Lung Interactions Play a Role?
  16. Automated delineation of brain structures in patients undergoing radiotherapy for primary brain tumors: From atlas to dose–volume histograms
  17. Pulmonary damage in Hodgkin's lymphoma patients treated with sequential chemo-radiotherapy: Predictors of radiation-induced lung injury
  18. Combined Imaging With 18F-FDG-PET/CT and 111In-Labeled Octreotide SPECT for Evaluation of Thymic Epithelial Tumors
  19. Abstract 80: Hodgkin‘s lymphoma advanced radiation treatment techniques: balance between late effects and secondary malignant neoplasms risk.
  20. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin
  21. In Regard to Boomsma et al
  22. Hodgkin’s lymphoma emerging radiation treatment techniques: trade-offs between late radio-induced toxicities and secondary malignant neoplasms
  23. Loss of CCDC6, the First Identified RET Partner Gene, Affects pH2AX S139 Levels and Accelerates Mitotic Entry upon DNA Damage
  24. Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin’s Lymphoma
  25. Development of multivariate NTCP models for radiation-induced hypothyroidism: a comparative analysis
  26. Dosimetric predictors of asymptomatic heart valvular dysfunction following mediastinal irradiation for Hodgkin’s lymphoma
  27. Fractionated Stereotactic Radiation Therapy for Orbital Optic Nerve Sheath Meningioma – a Single Institution Experience and a Short Review of the Literature
  28. Abstract 899: Patterns of distant and local relapses in breast cancer patients and triple negative subgroup
  29. Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques
  30. CD4+CD45RA+CXCR4+ lymphocytes are inversely associated with progression in stages I–III melanoma patients
  31. Preoperative Radiation Treatment for Rectal Cancer: Comparison of Target Coverage and Small Bowel NTCP in Conventional vs. 3D-Conformal Planning
  32. Radiation therapy in primary orbital lymphoma: a single institution retrospective analysis
  33. HMGA1 protein is a novel target of the ATM kinase
  34. Eric Hall and Amato J. Giaccia: Radiobiology for the radiologist, 6th edn.
  35. Randomized comparison of consolidation radiationversusobservation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans
  36. Essential Roles for Fe65, Alzheimer Amyloid Precursor-binding Protein, in the Cellular Response to DNA Damage
  37. ONYX-015 Enhances Radiation-Induced Death of Human Anaplastic Thyroid Carcinoma Cells
  38. Immune Defence: Role of Reactive Nitrogen Intermediates
  39. [43] Antioxidant effects of nitric oxide
  40. Nitric Oxide and Some Nitric Oxide Donor Compounds Enhance the Cytotoxicity of Cisplatin
  41. Convenient Colorimetric and Fluorometric Assays for S-Nitrosothiols
  42. The Effect of Various Nitric Oxide-Donor Agents on Hydrogen Peroxide-Mediated Toxicity: A Direct Correlation between Nitric Oxide Formation and Protection
  43. Chemical biology of nitric oxide: Regulation and protective and toxic mechanisms
  44. Determination of selectivity of reactive nitrogen oxide species for various substrates
  45. Nitric oxide (NO) protects against cellular damage by reactive oxygen species
  46. Cytoprotective Effects of NO against Oxidative Injury